[topsearch__bar__shortcode]

February 2022

How Did The Arbutus (ABUS) Stock Decline In Early Trades, Falling 1.99%?

Arbutus Biopharma Corporation (ABUS) has declined 1.99% at $3.19 in the current market on the last check Monday. The stock of Arbutus (ABUS) completed the previous trading session at $3.26. The price range of ABUS shares was between $3.115 and $3.28. It traded 1.68 million shares, which was below its daily average of 7.23 million […]

How Did The Arbutus (ABUS) Stock Decline In Early Trades, Falling 1.99%? Read More »

VEON Ltd. (VEON) Stock Dipped Today Despite Strong Financials

VEON Ltd. (VEON) is an international-level provider of connectivity and digital services. The company’s goal is to empower client ambitions via technology, acting as a digital concierge to direct their choices and link them with resources that equate to their requirements. The price of VEON stock during the early trading on February 28, 2022, was

VEON Ltd. (VEON) Stock Dipped Today Despite Strong Financials Read More »

RRGB Stock

How Did The ECMOHO Limited (MOHO) Stock Fall In The Pre-Market Session?

ECMOHO Limited (MOHO) shares were falling -6.08% to trade at $0.1868 in pre-market at last check. MOHO’s stock lost -2.79% to close Friday’s session at $0.1989. The stock volume remained 0.83 million shares, which was higher than the average daily volume of 0.4 million shares within the past 50 days. ECMOHO Limited shares have fallen

How Did The ECMOHO Limited (MOHO) Stock Fall In The Pre-Market Session? Read More »

Avalanche (AVAX) – Developments to watch out for 

Avalanche (AVAX) has been highly volatile during the past month and due to the volatility, the cryptocurrency had not been able to establish a steady trend. During the daily timeframe, the cryptocurrency has been bearish with a downside move of 7%; however, the overall outlook of the cryptocurrency persists to be bullish – especially with

Avalanche (AVAX) – Developments to watch out for  Read More »

AUPH Stock

Aurinia Pharmaceuticals Inc. (AUPH) is down in the Pre-market; here is why?

Aurinia Pharmaceuticals Inc. (AUPH) declined in the pre-market after announcing its fourth quarter and fiscal 2021 results. AUPH values at $13.10, losing more than 20% compared to yesterday’s closing price. The stock closed at $15.98 at the end of the last trading session. The stock volume traded in the last trading session was around 3.01

Aurinia Pharmaceuticals Inc. (AUPH) is down in the Pre-market; here is why? Read More »

CAN Stock

NeuroSense Therapeutics Ltd. (NRSN) Stock Rocketing Higher in Premarket. Here’s why.

NeuroSense Therapeutics Ltd. (NRSN) is a late-stage biotherapeutics company engaged in the discovery and development of therapeutics for patients with neurodegenerative diseases. The company believes that Amyotrophic Lateral Sclerosis, Alzheimer’s, and, Parkinson’s disease represent significant unmet medical needs nowadays. One of the pipeline candidates of the company is PrimeC in Phase 2 clinical studies for

NeuroSense Therapeutics Ltd. (NRSN) Stock Rocketing Higher in Premarket. Here’s why. Read More »

Coinbase and Block announces Financial Reports

Block, the payment behemoth, has reported great final quarter results for 2021, showing a shockingly brilliant standpoint for the year. Coinbase, a noticeable crypto trade, additionally detailed quarterly outcomes that beat examiner gauges, yet its assumptions for discounted exchanging volume and month-to-month executing clients the primary quarter of 2022 hauled down its stock cost. In

Coinbase and Block announces Financial Reports Read More »